(MENAFN- The Peninsula) The Peninsula
Doha: Qatar University College of Pharmacy (QU-CPH) MSc graduate recently conducted research to enhance the anti-colon cancer effect of curcumin, the main constituent in the Indian spice, turmeric.
The research involved utilising naturally occurring materials packaged into nano-particles for the treatment of colon cancer.
The nano-particles comprised of chitosan (obtained from chitin, the major constituent of the exoskeleton of arthropods) and modified citrus pectin (from rind of citrus fruits).
The data from the research suggests that the anti-colon cancer effects of curcumin was enhanced when encapsulated in the nanoparticles.
Areej Ali, recently defended her MSc thesis entitled,“Anticancer effects of modified citrus pectin and curcumin in chitosan nanoparticles on colon cancer.”
Areej said,“Our study confirmed the anticancer effect of the prepared nanoparticles on colon cancer cell lines.
This study has provided data that healthcare researchers can utilise to improve treatment outcomes.
“I am honoured to have had the chance to work on this project and obtaining such interesting findings.”
“I was able to present my research at the World Congresses on Sciences and Applied Sciences, winning the first place in poster presentations. I also, participated in the 11th Annual CPH Student Research Forum, winning the second place in poster presentations. I am co-recipient of two Qatar University student grant. I am very grateful for my journey and graduating from the College of Pharmacy at QU,” she added.
Areej was primarily supervised by Dr Nashiru Billa, Professor of Pharmaceutics, Qatar University. Co-supervisors include Professor Hesham Korashy, Professor of Pharmacology, Qatar University, and Professor Shahab Uddin, Senior Scientist & Head of Pathophysiology core facility, Translational Research Institute, Hamad Medical Corporation.
Prof Billa said,“Areej's work provides significant insights into utilising natural substances and applying novel formulation technologies to address the age-old issue of side effects arising from use of current chemotherapeutic agents.”
Dr. Fatima Mraiche, Section of Head of Research and Graduate Studies at QU-CPH highlighted that the research project will pave the way for novel treatment of colon cancer.
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.